VIB (Vlaams Instituut voor Biotechnologie) is a life sciences research institute founded by the Flemish government in 1995, headquartered in Ghent, Belgium. It translates basic research into biotech innovations by launching spin-off companies, managing intellectual property, and partnering with industry, having created over 40 spin-offs that have attracted nearly €2 billion in equity investment.
60% of their portfolio is in Biotech & Life Sciences.
Portfolio
18
Fund Size
—
Top Stage
Series A
Last 12 Mo
1
Team
AF
Ana Filipa Oliveira
Research associate translational research
AB
Alexander Botzki
Senior Manager - Training and Conferences
AF
Alvaro Furones Cuadrado
Senior Translational Research
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
25 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 MRM Health | Series B | — | Sep 2025 |
 Animab | Series B | — | Jul 2025 |
| Animab | Series B | — | Jan 2025 |
 Augustine Therapeutics | Series A | — | Jan 2025 |
| Augustine Therapeutics | Series A | — | Jun 2024 |
 Confo Therapeutics | Series B | — | Jan 2024 |
| TTanai Therapeutics | Seed | — | Dec 2023 |
 Aphea.bio | Series C | — | Jul 2023 |
 Dualyx | Series A | $44M | May 2023 |
| Dualyx | Series A | — | Jan 2023 |
 Muna Therapeutics | Series A | $73M | Jul 2021 |
 EXEVIR BIO | Series A | — | Mar 2021 |
| EExeVir | Series A | — | Jan 2021 |
 Ororatech | Series B | — | Nov 2020 |
| Confo Therapeutics | Series A | — | May 2019 |
 BIOTALYS NV | Series C | — | Jan 2019 |
 arGEN-X | Series A | — | Dec 2009 |
| AActoGeniX | Seed | — | Jun 2006 |
| AActoGeniX | Seed | — | Jan 2006 |
| AArgenx | Series B | — | — |
| arGEN-X | Series B | — | — |
 Rainbow Crops | Seed | — | — |
| MMultiplicom | Growth | — | — |
| BB-COS | Pre-Seed | — | — |
| Dualyx | Seed | — | — |
Top Co-Investors
PMV14 shared
BioGeneration Ventures6 shared
Forbion5 shared
Qbic4 shared
Gimv4 shared
Fund+4 shared
Gemma Frisius Fund3 shared
Viola Ventures3 shared
Novo Holdings A/S3 shared
High-Tech Gründerfonds3 shared
Astanor2 shared
Sofinnova Partners2 shared
Wellington Management2 shared
University of Michigan2 shared
Perceptive Advisors2 shared
Omnes Capital2 shared
Noshaq2 shared
UCB Ventures2 shared
Seventure Partners2 shared
EQT Life Sciences2 shared
Last updated: 7 October 2026